NL930043I1 - Werkwijze ter bereiding van een geneesmiddel met een cardiovasculaire werking op basis van een chinazolinederivaat en het daarbij toe te passen china zolinederivaat - Google Patents

Werkwijze ter bereiding van een geneesmiddel met een cardiovasculaire werking op basis van een chinazolinederivaat en het daarbij toe te passen china zolinederivaat

Info

Publication number
NL930043I1
NL930043I1 NL930043C NL930043C NL930043I1 NL 930043 I1 NL930043 I1 NL 930043I1 NL 930043 C NL930043 C NL 930043C NL 930043 C NL930043 C NL 930043C NL 930043 I1 NL930043 I1 NL 930043I1
Authority
NL
Netherlands
Prior art keywords
derivative
chinazoline
medicament
preparation
effect based
Prior art date
Application number
NL930043C
Other languages
English (en)
Other versions
NL930043I2 (nl
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NL930043I1 publication Critical patent/NL930043I1/nl
Publication of NL930043I2 publication Critical patent/NL930043I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL930043C 1978-02-06 1993-05-28 Werkwijze ter bereiding van een geneesmiddel met een cardiovasculaire werking op basis van een chinazolinederivaat, en het daarbij toe te passen chinazolinederivaat. NL930043I2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7803175A FR2421888A1 (fr) 1978-02-06 1978-02-06 Amides d'alkylene-diamines et leur application en therapeutique
FR7836819A FR2445323A2 (fr) 1978-02-06 1978-12-29 Amides d'alkylenediamines et leur application en therapeutique

Publications (2)

Publication Number Publication Date
NL930043I1 true NL930043I1 (nl) 1993-08-02
NL930043I2 NL930043I2 (nl) 1993-11-16

Family

ID=26220430

Family Applications (2)

Application Number Title Priority Date Filing Date
NLAANVRAGE7900917,A NL181482C (nl) 1978-02-06 1979-02-06 Werkwijze ter bereiding van een geneesmiddel met een cardiovasculaire werking op basis van een chinazolinederivaat, en het daarbij toe te passen chinazolinederivaat.
NL930043C NL930043I2 (nl) 1978-02-06 1993-05-28 Werkwijze ter bereiding van een geneesmiddel met een cardiovasculaire werking op basis van een chinazolinederivaat, en het daarbij toe te passen chinazolinederivaat.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NLAANVRAGE7900917,A NL181482C (nl) 1978-02-06 1979-02-06 Werkwijze ter bereiding van een geneesmiddel met een cardiovasculaire werking op basis van een chinazolinederivaat, en het daarbij toe te passen chinazolinederivaat.

Country Status (23)

Country Link
US (1) US4315007A (nl)
JP (1) JPS6023114B2 (nl)
AT (1) AT365176B (nl)
AU (1) AU521524B2 (nl)
BE (1) BE873909A (nl)
CA (1) CA1102330A (nl)
CH (1) CH637122A5 (nl)
DE (1) DE2904445C2 (nl)
DK (1) DK159316C (nl)
ES (1) ES477457A1 (nl)
FI (1) FI66861C (nl)
FR (2) FR2421888A1 (nl)
GB (1) GB2013679B (nl)
GR (1) GR66846B (nl)
IE (1) IE47812B1 (nl)
IL (1) IL56578A (nl)
IT (1) IT1192347B (nl)
LU (1) LU80880A1 (nl)
NL (2) NL181482C (nl)
NO (1) NO151463C (nl)
NZ (1) NZ189553A (nl)
PT (1) PT69178A (nl)
SE (1) SE449360B (nl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2466462A2 (fr) * 1978-02-06 1981-04-10 Synthelabo Derives d'alkylenediamines, leur preparation et leur application en therapeutique
EP0105838B1 (en) * 1982-09-30 1989-06-21 William John Louis 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
JPS6093016A (ja) * 1983-10-25 1985-05-24 Natl House Ind Co Ltd クランプ搬送装置
FR2577803B1 (fr) * 1985-02-26 1987-04-03 Synthelabo Compositions pharmaceutiques a base de nifedipine et d'alfuzosine
FR2570275B1 (fr) * 1984-09-14 1986-11-21 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'alfusozine
FR2577804B1 (fr) * 1985-02-26 1987-03-27 Synthelabo Compositions pharmaceutiques a base de verapamil et d'alfuzosine
EP0189336A1 (fr) * 1985-01-18 1986-07-30 Synthelabo Compositions pharmaceutiques contenant un alpha-bloquant et un antagoniste du calcium
FR2582513B1 (fr) * 1985-05-28 1988-08-05 Synthelabo Compositions pharmaceutiques contenant de l'alfuzosine
LU86672A1 (fr) * 1986-11-19 1988-06-13 Oreal Composition pour induire et stimuler la croissance des cheveux et diminuer la chute a base de derives d'alkylene diamino quinazoline
YU70890A (en) * 1989-04-21 1992-05-28 Egyt Gyogyszervegyeszeti Gyar Process for obtaining quinazoline derivatives
IL101243A (en) * 1991-03-20 1999-12-22 Merck & Co Inc Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history
FR2694495B1 (fr) * 1992-08-05 1994-09-23 Synthelabo Préparation pharmaceutique transdermique contenant de l'alfuzosine.
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
FR2717388B1 (fr) * 1994-03-21 1996-11-22 Synthelabo Formes galéniques à libération prolongée du chlorhydrate d'alfuzosine.
US6313294B1 (en) 1998-02-04 2001-11-06 Development Center For Biotechnology Process for preparing amides
HUP0104493A3 (en) 1998-09-30 2002-12-28 Takeda Pharmaceutical Drugs for improving vesical excretory strength
AU2001240150A1 (en) * 2000-03-13 2001-09-24 Chemrx Advanced Technologies, Inc. Quinazoline synthesis
US20020065286A1 (en) * 2000-08-21 2002-05-30 Davies Michael John Treatment of wounds
US20020091129A1 (en) * 2000-11-20 2002-07-11 Mitradev Boolell Treatment of premature ejaculation
GB0130219D0 (en) * 2001-12-18 2002-02-06 Pfizer Ltd Compounds for the treatment of sexual dysfunction
US20030229001A1 (en) * 2002-01-31 2003-12-11 Pfizer Inc. Treatment of male sexual dysfunction
GB0219961D0 (en) 2002-08-28 2002-10-02 Pfizer Ltd Oxytocin inhibitors
US7323462B2 (en) * 2002-12-10 2008-01-29 Pfizer Inc. Morpholine dopamine agonists
CA2451267A1 (en) * 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
WO2004054560A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Alpha-2-delta ligand to treat lower urinary tract symptoms
PA8597401A1 (es) * 2003-03-14 2005-05-24 Pfizer Derivados del acido 3-(1-[3-(1,3-benzotiazol-6-il) propilcarbamoil] cicloalquil) propanoico como inhibidores de nep
US20040220186A1 (en) * 2003-04-30 2004-11-04 Pfizer Inc. PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
US20050065158A1 (en) * 2003-07-16 2005-03-24 Pfizer Inc. Treatment of sexual dysfunction
US7291640B2 (en) * 2003-09-22 2007-11-06 Pfizer Inc. Substituted triazole derivatives as oxytocin antagonists
US20050267096A1 (en) * 2004-05-26 2005-12-01 Pfizer Inc New indazole and indolone derivatives and their use pharmaceuticals
US20050288270A1 (en) * 2004-05-27 2005-12-29 Pfizer Inc New aminopyridine derivatives and their use as pharmaceuticals
DE602004013644D1 (de) * 2004-09-16 2008-06-19 Hetero Drugs Ltd Kristalline alfuzosinbase
US7618972B2 (en) * 2005-03-21 2009-11-17 Pfizer Inc Substituted triazole derivatives as oxytocin antagonists
JP2008533193A (ja) * 2005-03-21 2008-08-21 ファイザー・リミテッド オキシトシン拮抗薬としての置換トリアゾール誘導体
CA2618103A1 (en) * 2005-08-10 2007-02-15 Pfizer Limited Substituted triazole derivatives as oxytocin antagonists
US20070066824A1 (en) * 2005-09-22 2007-03-22 Anumula Raghupathi R Preparation of alfuzosin
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
WO2007074364A1 (en) * 2005-12-26 2007-07-05 Aurobindo Pharma Limited Process for the preparation of alfuzosin
CN100564376C (zh) * 2006-09-19 2009-12-02 浙江华纳药业有限公司 阿夫唑嗪的制备方法
CN101190890B (zh) 2006-11-30 2011-04-27 江苏豪森药业股份有限公司 5-[(2r)-[2-[2-[2-(2,2,2-三氟乙氧基)苯氧基]乙基]氨基]丙基]-2-甲氧基苯磺酰胺
WO2008073388A2 (en) * 2006-12-11 2008-06-19 Mutual Pharmaceutical Company, Inc. Alfuzosin formulations, methods of making and methods of use
US20100092556A1 (en) * 2006-12-11 2010-04-15 Kristin Arnold Alfuzosin formulations, methods of making, and methods of use
US20100174073A1 (en) * 2007-05-04 2010-07-08 Actavis Group Ptc Ehf Process for the preparation of alfuzosin and salts thereof
WO2009001369A1 (en) * 2007-06-22 2008-12-31 Alembic Limited An improved process for the preparation of alfuzosin hydrochloride
WO2009007987A1 (en) * 2007-07-11 2009-01-15 Alembic Limited An improved process for the preparation of alfuzosin and its novel polymorph
NZ582950A (en) * 2007-08-02 2011-06-30 Cipla Ltd Process for the preparation of alfuzosin hydrochloride
US20090076043A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched alfuzosin
US20100183717A1 (en) * 2009-01-16 2010-07-22 Kristin Arnold Controlled-release formulations
CN107998090A (zh) * 2017-12-30 2018-05-08 威海贯标信息科技有限公司 一种阿夫唑嗪片组合物
CN113801069B (zh) * 2020-06-15 2024-03-15 鲁南制药集团股份有限公司 一种盐酸阿夫唑嗪中间体化合物
CN114573569B (zh) * 2022-03-30 2023-07-04 邦恩泰(山东)生物医药科技集团股份有限公司 一种异喹啉类化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
FR2350101A1 (fr) * 1976-05-07 1977-12-02 Synthelabo Nouvelles guanidines cyclisees
FR2362630A1 (fr) * 1976-08-24 1978-03-24 Synthelabo Derives d'alkylenediamines
DK140695C (da) * 1976-05-07 1980-05-12 Synthelabo Analogifremgangsmaade til fremstilling af 2,4-diamino-6,7-dimethoxyquinazolinderivater eller syreadditionssalte heraf
FR2389613A2 (en) * 1977-05-05 1978-12-01 Synthelabo Antihypertensive 4-amino-6,7-di:methoxy-quinazolyl alkylene di:amine - prepd. from a 2-halo-quinazoline and an alkylene di:amine

Also Published As

Publication number Publication date
NL181482C (nl) 1987-09-01
AU521524B2 (en) 1982-04-08
NL7900917A (nl) 1979-08-08
FR2421888B1 (nl) 1980-09-26
IE47812B1 (en) 1984-06-27
NZ189553A (en) 1981-05-01
PT69178A (fr) 1979-03-01
IL56578A (en) 1983-02-23
JPS54117487A (en) 1979-09-12
SE449360B (sv) 1987-04-27
DE2904445A1 (de) 1979-08-16
GB2013679B (en) 1982-09-02
NO151463C (no) 1985-04-17
JPS6023114B2 (ja) 1985-06-05
GB2013679A (en) 1979-08-15
SE7900987L (sv) 1979-08-07
FI66861B (fi) 1984-08-31
ATA84279A (de) 1981-05-15
AU4389579A (en) 1979-08-16
FR2421888A1 (fr) 1979-11-02
IE790210L (en) 1979-08-06
FR2445323A2 (fr) 1980-07-25
AT365176B (de) 1981-12-28
FR2445323B2 (nl) 1981-11-27
IT7919908A0 (it) 1979-02-05
BE873909A (fr) 1979-08-02
FI66861C (fi) 1984-12-10
CH637122A5 (fr) 1983-07-15
LU80880A1 (fr) 1980-09-24
NO151463B (no) 1985-01-02
CA1102330A (en) 1981-06-02
DK46079A (da) 1979-08-07
ES477457A1 (es) 1979-10-16
DK159316C (da) 1991-03-04
DE2904445C2 (de) 1986-10-30
IT1192347B (it) 1988-03-31
GR66846B (nl) 1981-05-05
NL930043I2 (nl) 1993-11-16
FI790369A (fi) 1979-08-07
DK159316B (da) 1990-10-01
IL56578A0 (en) 1979-05-31
NL181482B (nl) 1987-04-01
US4315007A (en) 1982-02-09
NO790358L (no) 1979-08-07

Similar Documents

Publication Publication Date Title
NL930043I1 (nl) Werkwijze ter bereiding van een geneesmiddel met een cardiovasculaire werking op basis van een chinazolinederivaat en het daarbij toe te passen china zolinederivaat
NL187515C (nl) Werkwijze voor het voorkomen van mastitis en daarbij te gebruiken preparaat.
NL175814C (nl) Werkwijze voor de bereiding van een radiologisch preparaat en voor de bereiding van een daarin te gebruiken trijoodisoftaalamide.
IT7822552A0 (it) Prodotti analoghi alla somatostatina e intermedi nella loro preparazione.
IT1123764B (it) Complesso di catetere @uretrale da buttare
NL178596C (nl) Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden.
NL7805477A (nl) Spuitgietmethode en daarbij toe te passen werkwijze.
GB2037754B (en) Threo - 3 -protected amino - 2 - hydroxy-4oxobutanoic acids or esters, their preparation and their use in the preparation of threo - 3 - amino - 2 - hydroxy-butanoylaminoacetic acids
IT1062511B (it) Metodo e composizione per rimuovere il virus dell'epatite da materiali biologici
IT7948314A0 (it) Dispositivo per la produzione dicorpi da modellare in materiali sintetici
DK163828C (da) Lactoner af cyclopropancarboxylsyrer til anvendelse ved fremstilling af cis-cyclopropancarboxylsyrer med diahalogenvinylkaede samt fremgangsmaade til fremtilling af sidstnaevnte cis-derivater
NL155011B (nl) Werkwijze ter bereiding van een herbicide preparaat en werkwijze ter bereiding van daarbij toe te passen oxadiazolonderivaten.
JPS54135077A (en) Ornament to be put on
NO792716L (no) 2,2-dmethyl-cyclopropancarboxylsyrer og estere som er anvendelige som utgangsmaterialer ved fremstilling av pyrethroider med insecticid virkning
FI790412A (fi) Anordning foer foerfarande av en pjaexa i skidor foer utfoersaokning eller vanlig terraengaokning
NO147717C (no) Depotsteroidestere for anvendelse i antikonsepsjonsmidler
IT1101187B (it) Metodo ed apaprato per unire materiali termoplastici
ZA764988B (en) Vinylthionophosphoric acid esters and their use as insecticides and acaricides
NL163514C (nl) Werkwijze voor het bereiden van een preparaat met anti- -allergische werking op basis van 1-oxo-1h-pyrimidoŸ1,2-aŸ chinoline-2-carbonzuurderivaten en werkwijze ter bereiding van een geneeskrachtige verbinding, geschikt voor gebruik bij de bereiding van genoemd preparaat.
IT1127716B (it) Dispositivo per impostare valori analogici
NL7809562A (nl) Farmaceutisch preparaat met anti-inflammatoire werking en werkwijze ter bereiding van het preparaat.
NL159579B (nl) Werkwijze ter bereiding van een preparaat met lipoproteine- spiegel verlagende werking; op basis van een clofibrine- zuurester en een 3-pyridylcarbinolderivaat en het onder toepassing daarvan verkregen gevormde preparaat.
JPS54145663A (en) N*nndimethylloopyrazolyllcarbamic acid ester* its preparation and use as incecticide
IT1126823B (it) Composti monoazoici impiegabili come coloranti e loro preparazione
SE7608679L (sv) Leksak i form av djurfigur med avtagbar sadel